Robert Blanks
Consejero General en ARDELYX, INC. .
Fortuna: 2 M $ al 30/04/2024
Cargos activos de Robert Blanks
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARDELYX, INC. | Consejero General | 01/08/2013 | - |
Historial de carrera de Robert Blanks
Antiguos cargos conocidos de Robert Blanks.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 02/02/2010 | 01/11/2012 |
IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2006 | 01/08/2009 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/04/2003 | 19/09/2008 |
Phaedrus Pharmaceuticals | Director Técnico/Científico/I+D | 01/01/1999 | 01/03/2003 |
Fundador | 01/01/1999 | 01/03/2003 | |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Corporate Officer/Principal | - | - |
Formación de Robert Blanks.
Boston College | Graduate Degree |
Bowdoin College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Operativa
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ARDELYX, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Health Technology |
Phaedrus Pharmaceuticals |
- Bolsa de valores
- Insiders
- Robert Blanks
- Experiencia